Hacker News
- First bit of success from a randomized trial of a COVID-19 treatment https://arstechnica.com/science/2020/04/first-treatment-for-sars-cov-2-shortens-recovery-time/ 2 comments
Linking pages
- Results from the remdesivir COVID-19 trial are out, and it’s good news | Ars Technica https://arstechnica.com/science/2020/05/the-antiviral-remdesivir-shortens-covid-19-recovery-times-study-shows/ 6 comments
- Stadia’s latest woe: Its PUBG port is overrun with official, crappy bots [Updated] | Ars Technica https://arstechnica.com/gaming/2020/04/stadias-latest-woe-its-pubg-port-is-overrun-with-official-crappy-bots/ 0 comments
Linked pages
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext 85 comments
- NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 | NIH: National Institute of Allergy and Infectious Diseases https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19 14 comments
- COVID-19: The biology of an effective therapy | Ars Technica https://arstechnica.com/science/2020/03/covid-19-the-biology-of-an-effective-therapy/ 0 comments
- Stadia’s latest woe: Its PUBG port is overrun with official, crappy bots [Updated] | Ars Technica https://arstechnica.com/gaming/2020/04/stadias-latest-woe-its-pubg-port-is-overrun-with-official-crappy-bots/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: First bit of success from a randomized trial of a COVID-19 treatment [Updated] | Ars Technica
See how to search.